Overview

Determination of Blood Loss After CS

Status:
Not yet recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
Comparing betweeen tranexamic acid plus oxytocin and oxytocin alone in their efficacy in reducing blood loss following CS
Phase:
Early Phase 1
Details
Lead Sponsor:
Ain Shams University
Treatments:
Oxytocin
Tranexamic Acid